Non Hodgkin Lymphoma Incidence and Mortality by Year, Black Individuals, New York City, 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Males and Females Males Females Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI Deaths Rate per 100,000 Population 95% CI Deaths Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Females 95% CI
1976 69 5.6 4.3-7.3 32 7.1 4.5-10.5 37 4.8 3.3-6.8 45 3.8 2.7-5.1 28 6.2 3.9-9.3 17 2.2 1.3-3.7
1977 72 5.6 4.3-7.2 29 5.7 3.5-8.6 43 5.6 4.0-7.7 37 3.0 1.9-4.3 14 2.2 1.1-3.9 23 3.2 1.9-5.1
1978 109 8.0 6.4-9.7 60 10.4 7.7-13.7 49 6.2 4.5-8.4 52 3.7 2.8-5.0 33 6.1 4.1-8.9 19 2.2 1.3-3.5
1979 85 6.8 5.3-8.6 48 9.2 6.5-12.5 37 5.2 3.5-7.3 50 4.5 3.2-6.1 24 5.2 3.0-8.1 26 4.0 2.5-6.0
1980 107 7.7 6.2-9.4 53 9.1 6.6-12.2 54 6.7 4.9-8.9 55 4.1 3.0-5.4 34 5.6 3.8-8.1 21 2.9 1.7-4.6
1981 99 7.4 5.9-9.2 46 7.1 4.9-10.0 53 7.2 5.3-9.6 60 4.4 3.3-5.8 26 4.8 3.0-7.3 34 4.2 2.8-5.9
1982 128 8.8 7.3-10.6 57 9.1 6.7-12.0 71 8.4 6.5-10.7 53 4.2 3.1-5.6 24 4.8 2.8-7.4 29 3.8 2.5-5.6
1983 132 8.7 7.2-10.4 62 9.9 7.4-13.0 70 7.9 6.1-10.0 73 5.1 3.9-6.4 39 6.3 4.3-9.0 34 4.2 2.8-5.9
1984 149 9.5 7.9-11.3 72 11.4 8.6-14.8 77 8.3 6.5-10.4 60 3.9 2.9-5.1 34 5.3 3.5-7.8 26 2.9 1.9-4.3
1985 186 11.3 9.6-13.1 97 13.7 10.8-17.1 89 9.5 7.6-11.8 83 5.3 4.1-6.7 41 5.9 4.0-8.4 42 4.8 3.4-6.5
1986 191 11.9 10.1-13.8 97 15.3 12.0-19.2 94 9.8 7.9-12.1 82 5.1 4.0-6.4 40 6.2 4.1-8.8 42 4.5 3.2-6.1
1987 202 11.8 10.1-13.6 121 17.8 14.4-21.7 81 7.9 6.2-9.9 77 4.5 3.5-5.6 38 5.5 3.7-7.9 39 3.8 2.7-5.3
1988 175 9.9 8.4-11.6 102 14.1 11.3-17.4 73 7.1 5.6-9.0 85 5.3 4.2-6.6 55 8.9 6.5-12.0 30 3.1 2.1-4.5
1989 203 11.3 9.7-13.0 118 15.1 12.2-18.4 85 8.3 6.6-10.3 87 5.1 4.1-6.4 51 7.5 5.3-10.1 36 3.6 2.5-5.0
1990 233 12.0 10.5-13.7 139 16.4 13.6-19.6 94 8.6 6.9-10.6 75 4.4 3.4-5.6 39 5.6 3.7-8.0 36 3.6 2.5-5.0
1991 238 12.9 11.2-14.7 135 16.9 13.9-20.4 103 9.8 8.0-12.0 75 4.4 3.4-5.6 43 5.8 4.0-8.1 32 3.3 2.2-4.7
1992 284 15.1 13.3-17.0 157 19.3 16.2-22.9 127 11.7 9.7-14.0 85 4.8 3.8-6.0 41 5.6 3.8-7.8 44 4.2 3.0-5.7
1993 272 13.2 11.7-14.9 170 19.1 16.2-22.4 102 8.8 7.1-10.7 78 4.2 3.3-5.3 39 5.0 3.5-7.0 39 3.6 2.5-5.0
1994 321 16.6 14.8-18.6 186 22.3 19.1-26.0 135 12.2 10.2-14.5 87 4.8 3.8-6.0 38 4.8 3.3-6.7 49 4.6 3.4-6.1
1995 283 14.6 12.9-16.4 168 20.5 17.3-24.1 115 10.3 8.5-12.4 85 4.6 3.6-5.7 49 6.1 4.4-8.2 36 3.4 2.4-4.7
1996 298 14.9 13.2-16.7 158 18.3 15.4-21.5 140 12.0 10.1-14.2 93 5.2 4.2-6.4 39 5.4 3.6-7.6 54 5.0 3.7-6.5
1997 330 16.6 14.8-18.5 187 22.6 19.2-26.3 143 12.4 10.4-14.6 95 5.3 4.2-6.5 49 6.8 4.9-9.1 46 4.2 3.1-5.6
1998 319 15.7 13.9-17.5 171 20.6 17.4-24.1 148 12.4 10.4-14.6 108 5.9 4.8-7.1 53 7.2 5.3-9.5 55 4.9 3.7-6.4
1999 333 15.9 14.2-17.7 176 20.5 17.4-24.0 157 12.7 10.8-14.9 114 5.7 4.7-6.9 64 8.5 6.4-11.0 50 4.2 3.1-5.5
2000 300 13.9 12.3-15.5 155 17.3 14.6-20.4 145 11.4 9.6-13.4 99 4.9 4.0-6.0 53 6.8 5.0-9.0 46 3.8 2.7-5.0
2001 311 14.6 13.0-16.3 161 18.4 15.6-21.7 150 11.9 10.1-14.0 111 5.4 4.5-6.6 57 6.7 5.0-8.7 54 4.4 3.3-5.8
2002 302 13.5 12.0-15.1 158 16.9 14.3-19.9 144 11.0 9.3-13.0 105 5.0 4.1-6.1 61 7.5 5.6-9.7 44 3.5 2.5-4.6
2003 342 15.4 13.8-17.1 158 17.5 14.7-20.6 184 14.0 12.0-16.2 109 5.0 4.1-6.1 57 6.8 5.1-9.0 52 4.0 3.0-5.2
2004 313 14.3 12.7-16.0 155 17.5 14.8-20.7 158 12.1 10.2-14.1 87 4.1 3.2-5.0 46 5.4 3.9-7.3 41 3.2 2.3-4.3
2005 365 16.1 14.5-17.9 175 18.7 15.9-21.8 190 14.3 12.3-16.5 91 4.3 3.4-5.3 45 5.5 3.9-7.4 46 3.6 2.6-4.8
2006 322 14.4 12.8-16.0 154 16.8 14.2-19.9 168 12.8 10.9-14.9 81 3.7 2.9-4.6 35 4.2 2.8-5.9 46 3.5 2.5-4.6
2007 356 15.6 14.0-17.3 196 20.3 17.5-23.5 160 12.0 10.2-14.1 100 4.5 3.7-5.5 45 5.3 3.8-7.2 55 4.1 3.1-5.4
2008 347 15.0 13.4-16.7 191 19.9 17.1-23.0 156 11.5 9.8-13.5 82 3.7 2.9-4.6 39 4.5 3.2-6.3 43 3.2 2.3-4.3
2009 381 16.8 15.1-18.6 185 19.7 16.9-22.9 196 14.7 12.7-16.9 86 3.8 3.0-4.7 40 4.5 3.2-6.2 46 3.4 2.5-4.5
2010 360 15.3 13.7-17.0 182 18.8 16.0-21.9 178 12.8 11.0-14.8 85 3.8 3.0-4.7 39 4.4 3.1-6.1 46 3.3 2.4-4.5
2011 413 17.2 15.5-19.0 213 22.4 19.4-25.8 200 13.8 12.0-15.9 92 4.0 3.2-4.9 49 5.4 3.9-7.2 43 3.1 2.2-4.2
2012 384 15.8 14.2-17.5 184 18.4 15.7-21.4 200 14.1 12.2-16.2 90 3.8 3.0-4.6 47 5.1 3.7-6.9 43 2.9 2.1-4.0
2013 392 15.6 14.0-17.2 192 18.5 15.9-21.5 200 13.5 11.7-15.6 95 3.9 3.1-4.8 50 5.4 4.0-7.2 45 3.0 2.2-4.0
2014 421 16.3 14.8-18.0 219 20.6 17.9-23.6 202 13.3 11.5-15.4 93 3.7 2.9-4.5 47 4.9 3.5-6.5 46 3.0 2.2-4.0
2015 397 15.5 14.0-17.1 189 18.2 15.6-21.1 208 13.6 11.8-15.6 88 3.6 2.9-4.4 41 4.6 3.2-6.3 47 3.1 2.3-4.2
2016 438 17.0 15.4-18.7 213 20.4 17.6-23.4 225 14.8 12.9-16.9 96 3.8 3.1-4.7 45 4.5 3.2-6.0 51 3.3 2.4-4.4
2017 419 16.1 14.5-17.7 193 17.9 15.4-20.8 226 15.0 13.0-17.1 87 3.4 2.7-4.2 43 4.2 3.0-5.8 44 2.8 2.0-3.8
2018 400 15.3 13.8-16.9 208 19.3 16.7-22.2 192 12.4 10.7-14.3 86 3.2 2.6-4.0 49 4.8 3.5-6.4 37 2.3 1.6-3.2
2019 408 15.3 13.8-16.9 204 18.6 16.1-21.4 204 13.3 11.5-15.4 103 3.8 3.1-4.7 56 5.2 3.9-6.8 47 2.9 2.1-3.9
2020 352 13.2 11.9-14.7 187 17.1 14.6-19.8 165 10.6 9.0-12.4 69 2.5 2.0-3.2 42 3.7 2.7-5.1 27 1.7 1.1-2.5

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.